Login

Entrevista com Rogério Jorge, CEO da AES Brasil, com foco na geração de energia no Brasil. 00:10:00

Share On Facebook Share On Twitter

Rogério Jorge. President of AES Brasil 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
John Garrity on Maxim Group's Evolution and Emphasis on Client Relationships
00:10:00
Vallourec CEO Unveils 2023 Results Following the Successful Implementation of the New Vallourec Plan| Philippe Guillemot, CEO, Vallourec SA.
00:10:00
Steve McGovern, CEO of Dubber Corporation, delivers a presentation at the NWR Communications Virtual Conference following the removal of the Managing Director position within the company.|Peter Edward Pawlowitsch is currently the Chief Executive Officer a
00:10:00
Valens Semiconductor CEO Gideon Ben-Zvi discusses moving data through cables and related innovations.
00:10:00
Pursuit Minerals CEO Discusses Advanced Vanadium Projects in Scandinavia and Rapid Project Development Strategies
00:10:00
where it currently exists versus Where the world is headed |Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
Investing Strategies During a Looming Recession | David Hefty - CHIEF EXECUTIVE OFFICER of Credent Wealth Management
00:00:00
BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl
00:10:00
Unveiling the Potential of Basin Gulch: Lannister Mining's Journey
00:10:00
4D Medical Achieves Milestone: Generates First Clinical SAS Revenue and Explores International Expansion with Revolutionary Respiratory Imaging Technology| Dr Andreas Fouras, CEO, 4dmedical ltd.
00:10:00
Marathoon Fund Management , Managing Director at Firefinch Limited
00:10:00
Reflections on Jimmy Hoffa's Disappearance and Legacy|Jack Goldsmith

© 2017 - Neuhu+